GGrantIndex
← Leaderboards

Scott Rothbart

Van Andel Research Institute

$7,899,994
Attributed
$7,899,994
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.6M · FY201425
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,899,994 · 7

By mechanism

R35$3,411,800 · 2
P50$2,266,490 · 2
R01$1,264,638 · 1
R00$746,016 · 1
K99$211,050 · 1

Top collaborators

No co-investigators on record.

Most similar at Van Andel Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Chromatin

Research focus

ChromatinEpigenetic ProcessDna MethylationCellsMalignant NeoplasmsDna Modification MethylasesProgramsHistonesSignal TransductionPost-Translational Protein ProcessingProteinsMolecularTumor Suppressor GenesCancer CellHistone H3Pathway InteractionsUbiquitin-Protein LigaseGenetic TranscriptionEpigenetic RegulationRegulationGenesResponseDna Methylation RegulationBiology

Grant awards (19)

Mechanisms of DNA methylation signaling and dysregulation in colon cancer$632,319
R01 · FY2025 · CA · contact PI
Molecular mechanisms of chromatin signaling and epigenetic regulation$518,400
R35 · FY2025 · GM · contact PI
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors$480,188
P50 · FY2025 · CA · contact PI
Mechanisms of DNA methylation signaling and dysregulation in colon cancer$632,319
R01 · FY2024 · CA · contact PI
Molecular mechanisms of chromatin signaling and epigenetic regulation$518,400
R35 · FY2024 · GM · contact PI
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors$460,981
P50 · FY2024 · CA · contact PI
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors$446,575
P50 · FY2023 · CA · contact PI
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors$446,575
P50 · FY2022 · CA · contact PI
Molecular mechanisms of chromatin and epigenetic regulation$475,000
R35 · FY2021 · GM · contact PI
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors$432,171
P50 · FY2021 · CA · contact PI
Molecular mechanisms of chromatin and epigenetic regulation$475,000
R35 · FY2020 · GM · contact PI
Molecular mechanisms of chromatin and epigenetic regulation$475,000
R35 · FY2019 · GM · contact PI
Molecular mechanisms of chromatin and epigenetic regulation$475,000
R35 · FY2018 · GM · contact PI
Molecular mechanisms of chromatin and epigenetic regulation$475,000
R35 · FY2017 · GM · contact PI
Mechanisms Regulating DNA Methylation Maintenance in Chromatin$248,672
R00 · FY2017 · CA · contact PI
Mechanisms Regulating DNA Methylation Maintenance in Chromatin$248,672
R00 · FY2016 · CA · contact PI
Mechanisms Regulating DNA Methylation Maintenance in Chromatin$248,672
R00 · FY2015 · CA · contact PI
Mechanisms Regulating DNA Methylation Maintenance in Chromatin$105,605
K99 · FY2015 · CA · contact PI
Mechanisms Regulating DNA Methylation Maintenance in Chromatin$105,445
K99 · FY2014 · CA · contact PI